Live corpus
Active intelligence prompt Pediatric cancer: surface high-value therapeutic signals across pediatric oncology literature.
PEDIATRIC CANCER RESEARCH INTELLIGENCE

Finding therapies hidden in 40,244 pediatric cancer papers.

Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.

40,244 Papers indexed
1,440 Papers AI scored
40,244 Ranked papers
100.0% Coverage
PATIENT-FRIENDLY SUMMARY

CHIP-AML22: a complex clinical trial in de novo pediatric AML patients, including a gemtuzumab ozogamicin randomization and targeted therapy with quizartinib in eligible subgroups, within the NOPHO-DB-SHIP consortium.

For education only—not personal medical advice.

LIVE PEDIATRIC ONCOLOGY INTELLIGENCE
↑ Therapeutic signals emerging ↑ New pediatric cancer papers ingested ↑ Cross-paper convergence detected ↑ Human relevance scores updating ↑ Overlooked treatment paths surfacing
TOP PEDIATRIC CANCER SIGNALS

Ranked Discovery Journal Articles

View all discoveries →
LATEST PEDIATRIC CANCER PAPERS

Database feed

Last ingest 2026-11-08 10:15 AM
PEDIATRIC CANCER RESEARCH TERMINAL

All ranked pediatric cancer papers

40244 results
D
Incidentally discovered urothelial papilloma in a 9-year-old girl.
PMID 42005295 Published: 2026-03-28 Ingested: 2026-08-02 12:06 AM Urology case reports
AI -
Standard 54.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 54.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 65.0.

D
Inpatient Food Insecurity and Pediatric Hematology Oncology Hospitalization Outcomes.
PMID 42003715 Published: 2026-04-20 Ingested: 2026-08-02 12:06 AM Pediatric blood & cancer
AI -
Standard 54.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 54.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 65.0.

D
Metastatic rosette-forming glioneuronal tumour presenting as isolated primary amenorrhoea.
PMID 41986065 Published: 2026-04-15 Ingested: 2026-08-02 12:06 AM BMJ case reports
AI -
Standard 54.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 54.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 65.0.

D
Primary Ovarian Leiomyoma in a 2-year-old Child: Youngest Worldwide and First Report from India with Review of Literature.
PMID 41958790 Published: 2026-01-21 Ingested: 2026-08-02 12:06 AM Journal of Indian Association of Pediatric Surgeons
AI -
Standard 54.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 54.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 65.0.

D
Rare somatic manifestations of telomere biology disorders.
PMID 41956864 Published: 2026-03-13 Ingested: 2026-08-02 12:05 AM Seminars in hematology
AI -
Standard 54.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 54.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 65.0.

D
True Positive 18 F-FDG PET/CT and Negative 123 I-MIBG SPECT/CT in a Pediatric Patient With Bladder Malignant Paraganglioma.
PMID 41950229 Published: 2026-03-31 Ingested: 2026-08-02 12:06 AM Clinical nuclear medicine
AI -
Standard 54.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 54.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 65.0.

D
Benign Surgery, Malignant Rhythm: Post-laparoscopic Sick Sinus Syndrome in a Child.
PMID 41939666 Published: 2026-03-03 Ingested: 2026-08-02 12:06 AM Cureus
AI -
Standard 54.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 54.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 65.0.

D
[Primary malignant bone tumours-part 1].
PMID 41922581 Published: 2026-04-01 Ingested: 2026-08-02 12:06 AM Radiologie (Heidelberg, Germany)
AI -
Standard 54.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 54.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 65.0.

D
Pediatric Fourth Ventricular Atypical Meningioma With a Whorling-Sclerosing Pattern: A Report of a Rare Tumor.
PMID 41917798 Published: 2026-03-31 Ingested: 2026-08-02 12:06 AM International journal of surgical pathology
AI -
Standard 54.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 54.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 65.0.

Previous
Page 2711 of 3354
Next
Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic